Comparative Proteomics Reveals Novel Components at the Plasma Membrane of Differentiated HepaRG Cells and Different Distribution in Hepatocyte- and Biliary-Like Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Petrareanu, Catalina ^a,b   Macovei, Alina ^a   Sokolowska, Izabela ^c   Woods, Alisa G ^c   Lazar, Catalin ^a   Radu, Gabriel L ^b   Darie, Costel C ^c   Branza Nichita, Norica ^a  

^a INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^c CLARKSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CATHEPSIN K; CYCLOPHILIN A; LIPOCORTIN 1; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A4; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; BILIARY LIKE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; CELL STRAIN; CELL STRAIN HEPARG; CELL TYPE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MEMBRANE; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN TRANSPORT; PROTEOME; PROTEOMICS; UP-REGULATION;

EID: 84882622610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071859     Document Type: Article

References (55)

1. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
2. Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, et al. (2007) The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168: 66-73.
3. Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, et al. (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45: 957-967.
4. Darnell M, Ulvestad M, Ellis E, Weidolf L, Andersson TB, (2012) In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system. J Pharmacol Exp Ther 343: 134-144.
5. Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, et al. (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28: 69-87.
6. Josse R, Aninat C, Glaise D, Dumont J, Fessard V, et al. (2008) Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies. Drug Metab Dispos 36: 1111-1118.
7. Parent R, Beretta L, (2008) Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells. Genome Biol 9: R19.
8. Ndongo-Thiam N, Berthillon P, Errazuriz E, Bordes I, De Sequeira S, et al. (2011) Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology 54: 406-417.
9. Sureau C, (2010) The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model. Methods Mol Biol 640: 463-473.
10. Raney AK, McLachlan A (1991) Molecular Biology of the Hepatitis B Virus. Molecular Biology of the Hepatitis B Virus: CRC, Boca Raton, FL. 1-37.
11. Glebe D, Urban S, (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13: 22-38.
12. Walter E, Keist R, Niederost B, Pult I, Blum HE, (1996) Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24: 1-5.
13. Lereau M, Gouas D, Villar S, Besaratinia A, Hautefeuille A, et al. (2012) Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells. J Gen Virol 93: 640-650.
14. Macovei A, Radulescu C, Lazar C, Petrescu S, Durantel D, et al. (2010) Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J Virol 84: 243-253.
15. Schulze A, Mills K, Weiss TS, Urban S, (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55: 373-383.
16. Macovei A, Petrareanu C, Lazar C, Florian P, Branza-Nichita N, (2013) Regulation of hepatitis B virus infection by Rab5, rAb7, and the endolysosomal compartment. J Virol 87: 6415-6427.
17. Aebersold R, Mann M, (2003) Mass spectrometry-based proteomics. Nature 422: 198-207.
18. Ngounou Wetie AG, Sokolowska I, Woods AG, Roy U, Loo JA, et al. (2013) Investigation of stable and transient protein-protein interactions: Past, present, and future. Proteomics 13: 538-557.
19. Ngounou Wetie AG, Sokolowska I, Wormwood KL, Beglinger K, Michel TM, et al. (2013) Mass spectrometry for the detection of potential psychiatric biomarkers. J Mol Psychiatry 1: 8.
20. Woods AG, Ngounou Wetie AG, Sokolowska I, Russell S, Ryan JP, et al. (2013) Mass spectrometry as a tool for studying autistic spectrum disorder. J Mol Psychiatry 1: 6.
21. Narayan R, Gangadharan B, Hantz O, Antrobus R, Garcia A, et al. (2009) Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection. J Proteome Res 8: 118-122.
22. Sokolowska I, Dorobantu C, Woods AG, Macovei A, Branza-Nichita N, et al. (2012) Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells. Proteome Sci 10: 47.
23. Marion MJ, Hantz O, Durantel D, (2010) The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies. Methods Mol Biol 640: 261-272.
24. Woods AG, Sokolowska I, Darie CC, (2012) Identification of consistent alkylation of cysteine-less peptides in a proteomics experiment. Biochem Biophys Res Commun 419: 305-308.
25. Darie CC, Deinhardt K, Zhang G, Cardasis HS, Chao MV, et al. (2011) Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry. Proteomics 11: 4514-4528.
26. Sokolowska I, Gawinowicz MA, Ngounou Wetie AG, Darie CC, (2012) Disulfide proteomics for identification of extracellular or secreted proteins. Electrophoresis 33: 2527-2536.
27. Ponka P, Lok CN, (1999) The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31: 1111-1137.
28. Jemc J, Rebay I, (2007) Identification of transcriptional targets of the dual-function transcription factor/phosphatase eyes absent. Dev Biol 310: 416-429.
29. Yonemura S, Nagafuchi A, Sato N, Tsukita S, (1993) Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J Cell Biol 120: 437-449.
30. Pshezhetsky AV, Fedjaev M, Ashmarina L, Mazur A, Budman L, et al. (2007) Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics 7: 2201-2215.
31. Caffrey M, (2011) HIV envelope: challenges and opportunities for development of entry inhibitors. Trends Microbiol 19: 191-197.
32. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R, (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9: 369-381.
33. Cosset FL, Lavillette D, (2011) Cell entry of enveloped viruses. Adv Genet 73: 121-183.
34. Della Gaspera B, Braut-Boucher F, Bomsel M, Chatelet F, Guguen-Guillouzo C, et al. (2001) Annexin expressions are temporally and spatially regulated during rat hepatocyte differentiation. Dev Dyn 222: 206-217.
35. Rai T, Mosoian A, Resh MD, (2010) Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J Virol 84: 9783-9792.
36. Yang SL, Chou YT, Wu CN, Ho MS, (2011) Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85: 11809-11820.
37. Ma H, Kien F, Maniere M, Zhang Y, Lagarde N, et al. (2012) Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection. J Virol 86: 1789-1801.
38. Gong ZJ, De Meyer S, van Pelt J, Hertogs K, Depla E, et al. (1999) Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Hepatology 29: 576-584.
39. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-416.
40. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568.
41. Liu X, Zhao Z, Liu W, (2013) Insights into the roles of cyclophilin A during influenza virus infection. Viruses 5: 182-191.
42. Tian X, Zhao C, Zhu H, She W, Zhang J, et al. (2010) Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection. J Virol 84: 3373-3381.
43. Turano C, Coppari S, Altieri F, Ferraro A, (2002) Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 193: 154-163.
44. Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, et al. (2012) Endothelial cell surface expression of protein disulfide isomerase activates beta1 and beta3 integrins and facilitates dengue virus infection. J Cell Biochem 113: 1681-1691.
45. Arkona C, Wiederanders B, (1996) Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue. Biol Chem 377: 695-702.
46. Knight CG, Barrett AJ, (1976) Interaction of human cathepsin D with the inhibitor pepstatin. Biochem J 155: 117-125.
47. Chen B, Piel WH, Gui L, Bruford E, Monteiro A, (2005) The HSP90 family of genes in the human genome: insights into their divergence and evolution. Genomics 86: 627-637.
48. Meng SD, Gao T, Gao GF, Tien P, (2001) HBV-specific peptide associated with heat-shock protein gp96. Lancet 357: 528-529.
49. Meunier L, Usherwood YK, Chung KT, Hendershot LM, (2002) A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 13: 4456-4469.
50. Forsythe HL, Jarvis JL, Turner JW, Elmore LW, Holt SE, (2001) Stable association of hsp90 and p23, but Not hsp70, with active human telomerase. J Biol Chem 276: 15571-15574.
51. Nemoto T, Ohara-Nemoto Y, Ota M, Takagi T, Yokoyama K, (1995) Mechanism of dimer formation of the 90-kDa heat-shock protein. Eur J Biochem 233: 1-8.
52. Rasmussen RK, Ji H, Eddes JS, Moritz RL, Reid GE, et al. (1997) Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis 18: 588-598.
53. Sokolowska I, Woods AG, Gawinowicz MA, Roy U, Darie CC, (2012) Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells. FEBS J 279: 2579-2594.
54. Sokolowska I, Woods AG, Gawinowicz MA, Roy U, Darie CC, (2012) Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells. J Biol Chem 287: 1719-1733.
55. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272.